DE602006010565D1 - Kristallines azithromycin-l-malat-monohydrat und pharmazeutische zusammensetzung, die dieses enthält - Google Patents

Kristallines azithromycin-l-malat-monohydrat und pharmazeutische zusammensetzung, die dieses enthält

Info

Publication number
DE602006010565D1
DE602006010565D1 DE602006010565T DE602006010565T DE602006010565D1 DE 602006010565 D1 DE602006010565 D1 DE 602006010565D1 DE 602006010565 T DE602006010565 T DE 602006010565T DE 602006010565 T DE602006010565 T DE 602006010565T DE 602006010565 D1 DE602006010565 D1 DE 602006010565D1
Authority
DE
Germany
Prior art keywords
pharmaceutical composition
composition containing
crystalline azithromycin
malate monohydrate
malate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602006010565T
Other languages
English (en)
Inventor
Bo Sung Kwon
Eun Sook Kim
Hee Cheol Kim
Sangmin Yun
Myoung-Sil Ko
Tae Hun Song
Han Kyong Kim
Kwee Hyun Suh
Gwansun Lee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hanmi Pharmaceutical Co Ltd
Hanmi Pharmaceutical Industries Co Ltd
Original Assignee
Hanmi Pharmaceutical Co Ltd
Hanmi Pharmaceutical Industries Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hanmi Pharmaceutical Co Ltd, Hanmi Pharmaceutical Industries Co Ltd filed Critical Hanmi Pharmaceutical Co Ltd
Publication of DE602006010565D1 publication Critical patent/DE602006010565D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
DE602006010565T 2005-06-08 2006-06-05 Kristallines azithromycin-l-malat-monohydrat und pharmazeutische zusammensetzung, die dieses enthält Active DE602006010565D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020050048923A KR100666091B1 (ko) 2005-06-08 2005-06-08 아지스로마이신 l-말산염 일수화물 및 이를 포함하는 약학조성물
PCT/KR2006/002157 WO2006132486A1 (en) 2005-06-08 2006-06-05 Crystalline azithromycin l-malate monohydrate and pharmaceutical composition containing same

Publications (1)

Publication Number Publication Date
DE602006010565D1 true DE602006010565D1 (de) 2009-12-31

Family

ID=37498652

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602006010565T Active DE602006010565D1 (de) 2005-06-08 2006-06-05 Kristallines azithromycin-l-malat-monohydrat und pharmazeutische zusammensetzung, die dieses enthält

Country Status (13)

Country Link
US (1) US20090318375A1 (de)
EP (1) EP1910392B1 (de)
JP (1) JP2008543749A (de)
KR (1) KR100666091B1 (de)
CN (1) CN101193904A (de)
AT (1) ATE449102T1 (de)
AU (1) AU2006255914B2 (de)
CA (1) CA2610449A1 (de)
DE (1) DE602006010565D1 (de)
ES (1) ES2333610T3 (de)
IL (1) IL187639A0 (de)
RU (1) RU2348644C1 (de)
WO (1) WO2006132486A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8106111B2 (en) 2009-05-15 2012-01-31 Eastman Chemical Company Antimicrobial effect of cycloaliphatic diol antimicrobial agents in coating compositions
RU2512683C2 (ru) 2012-06-08 2014-04-10 Общество с ограниченной ответственностью "ВИК-здоровье животных" Антибактериальная инъекционная фармацевтическая композиция
CN115057814A (zh) * 2021-12-07 2022-09-16 山东新时代药业有限公司 一种米力农苹果酸盐晶体

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4474768A (en) * 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
WO2001049697A1 (en) * 2000-01-04 2001-07-12 Teva Pharmaceutical Industries Ltd. Preparation method of azithromycin dihydrate
ES2162764B1 (es) * 2000-05-17 2003-04-01 Ercros Ind Sa Forma polimorfica del dihidrato de azitromicina, y su procedimiento deobtencion.
WO2002042315A2 (en) * 2000-11-27 2002-05-30 Biochemie S.A. Macrolide solvates
KR100491183B1 (ko) * 2001-03-21 2005-05-25 한미약품 주식회사 아지트로마이신의 제조방법 및 이 방법에 사용되는9-데옥소-9에이-아자-9에이-호모에리트로마이신 에이의결정성 수화물
KR100431431B1 (ko) * 2001-04-25 2004-05-14 한미약품 주식회사 아지트로마이신 수화물의 1,2-프로필렌글리콜 내포화합물,그의 제조방법 및 그의 약학적 조성물
US6855813B2 (en) * 2002-07-19 2005-02-15 Alembic Limited Process for the preparation of azithromycin monohydrate
ES2220229B1 (es) 2003-05-29 2005-10-16 Quimica Sintetica, S.A. Sales de adicion de azitromicina y acido citrico y procedimiento para su obtencion.
GB2395482A (en) * 2003-07-03 2004-05-26 Jubilant Organosys Ltd Process for preparing non-hygroscopic azithromycin dihydrate

Also Published As

Publication number Publication date
ES2333610T3 (es) 2010-02-24
EP1910392B1 (de) 2009-11-18
JP2008543749A (ja) 2008-12-04
AU2006255914A1 (en) 2006-12-14
CN101193904A (zh) 2008-06-04
EP1910392A1 (de) 2008-04-16
KR100666091B1 (ko) 2007-01-10
IL187639A0 (en) 2008-03-20
ATE449102T1 (de) 2009-12-15
US20090318375A1 (en) 2009-12-24
AU2006255914B2 (en) 2009-09-03
WO2006132486A1 (en) 2006-12-14
EP1910392A4 (de) 2008-10-29
KR20060128066A (ko) 2006-12-14
CA2610449A1 (en) 2006-12-14
RU2348644C1 (ru) 2009-03-10

Similar Documents

Publication Publication Date Title
NL301039I1 (nl) Fostamatinib of een farmaceutisch aanvaardbaar zout van fostamatinib, of een hydraat, solvaat of N-oxide van fostamatinib of het farmaceutisch aanvaardbare zout van fostamatinib, in het bijzonder dinatriumfostamatinib eventueel in de vorm van een hydraat
EP1962838A4 (de) Farnesoid-x-rezeptor-agonisten
NO20092611L (no) Krystallinsk faststoff Rasagilin base
WO2007125547A3 (en) Novel process for statins and its pharmaceutically acceptable salts thereof
TW200734344A (en) Antibacterial agents
IL182869A0 (en) Non-hygroscopic and powdery amorphous pimecrolimus
CL2007002100A1 (es) Compuestos derivados biciclicos que contienen nitrogeno, sus sales, solvatos y n-oxidos; composicion farmaceutica; y uso para el tratamiento de infecciones bacterianas.
AR054114A1 (es) Composiciones farmaceuticas que comprenden imatinib y un retardador de la liberacion
TW200744588A (en) Pharmaceutical composition for external use
TW200720232A (en) Crystalline solid forms of tigecycline and methods of preparing same
FI20055416A0 (fi) Bioabsorvoituva nauhajärjestelmä, bioabsorboituva nauha, menetelmä bioabsorboituvan nauhan valmistamiseksi, bioabsorboituvan nauhan neulajärjestelmä sekä lukitusmekanismi
WO2006120563A3 (en) Antibacterial agents
MY140739A (en) 2, 6-quinolinyl derivatives, processes for preparing them and their uses
ATE490958T1 (de) Als agonisten für den nikotinischen acetylcholinrezeptor geeignete azabicycloalkanderivate
FR2903983B1 (fr) Procede de fabrication de diesters.
MX274842B (es) Procedimiento para la produccion de sales de (4,5-dihidroisoxazol- 3-il)tiocarboxamidina.
DE602004012269D1 (de) Quervernetzte glycopeptid-cephalosporin-antibiotika
SG170054A1 (en) Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives
DE602004024393D1 (de) Quervernetzte glycopeptid-cephalosporin-antibiotika
HK1114516A1 (en) Substituted sulfoxide compounds, methods for preparing the same and use thereof
CL2007001542A1 (es) Compuestos derivados de aminotiazoles, composicion farmaceutica; y uso para el tratamiento de infecciones bacterianas.
SG148168A1 (en) Genetically modified microorganism and process for production of macrolide compound using the microorganism
GB2456096A (en) Crystalline form of benzothiophene compound and process for preparation thereof
DE602006010565D1 (de) Kristallines azithromycin-l-malat-monohydrat und pharmazeutische zusammensetzung, die dieses enthält
NI200700175A (es) Procesos para la preparación de alcoholes de aminoetoxibencilo

Legal Events

Date Code Title Description
8364 No opposition during term of opposition